Tags Posts tagged with "SRPT"

SRPT

Sarepta Therapeutics SRPT Stock News

0 1144
Sarepta Therapeutics Inc (NASDAQ: SRPT) Sarepta Therapeutics didn't look like it was going to have the best of days in the market today. While the...
Sarepta Therapeutics SRPT Stock News

0 1175
Sarepta Therapeutics Inc (NASDAQ: SRPT) Sarepta Therapeutics isn't having the strongest of days in the market today. However, that may change relatively soon. Early this...
Sarepta Therapeutics Inc SRPT Stock News

0 837
Sarepta Therapeutics Inc (NASDAQ: SRPT) Sarepta Therapeutics was having an incredibly rough day in the market today. In fact, just minutes ago, the stock was...
Sarepta Therapeutics SRPT Stock News

0 1153
Sarepta Therapeutics IncĀ (NASDAQ: SRPT) During the past year, I have struggled in coming to grips with how and why Sarepta Therapeutics is on the verge...
Sarepta Therapeutics Inc SRPT Stock News

0 1895
Sarepta Therapeutics Inc (NASDAQ: SRPT) Sarepta Therapeutics is off to a rough start to the trading day today. However, I believe that this is likely...
Sarepta Therapeutics Inc SRPT Stock News

0 1541
Sarepta Therapeutics Inc (NASDAQ: SRPT) If you follow Sarepta Therapeutics, you know about Eteplirsen. The treatment is designed to address several diseases, including Duchenne muscular...
Sarepta Therapeutics SRPT Stock News

0 2153
Sarepta Therapeutics Inc (NASDAQ: SRPT) Sarepta Therapeutics is having a strong day in the market today, and for good reason. It seems as though Anthem...
Sarepta Therapeutics SRPT Stock News

0 2388
Sarepta Therapeutics Inc (NASDAQ: SRPT) If you've been watching Sarepta Therapeutics recently, chances are that the word opportunity comes to mind quite a bit. After...
Sarepta Therapeutics SRPT Stock News

0 945
Sarepta Therapeutics Inc (NASDAQ: SRPT) Sarepta Therapeutics is having an incredible day in the market today, and for good reason. A key figure has left...
Sarepta Therapeutics SRPT Stock News

0 1339
Sarepta Therapeutics Inc (NASDAQ: SRPT) Sarepta Therapeutics is having an incredible day in the market today. After announcing news from the FDA, the stock has...

Thought Leader Discussions

Josh Disbrow head shot1 (1)

0 1502
Aytu Bioscience Inc (OTCMKTS: AYTU) Recently, the CNA Finance team had an opportunity to speak with Josh Disbrow, CEO of Aytu Bioscience. Josh Disbrow has...